Get our newsletter delivered directly to your inbox
I have already subscribed | Do not show this message again
Boletines
Your email has been successfully registered.
According to the results of phase III of the Sputnik V clinical trials published by the scientific magazine The Lancet, the vaccine has 91.6 safety and efficacy, which turns it into one of the most reliable COVID-19 vaccines worldwide.
The Russian Ambassador to Tunisia Sergei Nikolaev reported on Thursday that both countries are negotiating the acquisition of the Sputnik V vaccine as soon as possible.
"The Tunisian Ministry of Health approved on January 30 the use [of Sputnik V] in the national territory. The supply of the Russian vaccine is being negotiated in the shortest possible time," the official said.
Thus far Algeria, Nigeria, and Tunisia have registered the Sputnik V vaccine in Africa. This week Russian authorities expect the vaccine to be registered in 25 countries with larger markets such as Brazil and India.
According to the results of phase III of the Sputnik V clinical trials published by the scientific magazine The Lancet, the vaccine has 91.6 safety and efficacy, which turns it into one of the most reliable COVID-19 vaccines worldwide.
#FromTheSouth News Bits | Union for Hope coalition leader and presidential candidate Andres Arauz signed a preliminary agreement with Russia for the supply of Sputnik V, adding to the commitment made by Argentina to provide Ecuador with 4.4 million doses of the Russian vaccine. pic.twitter.com/VDebUny6qy